Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Anticancer Research|May 16, 2000
The clinical value of p21WAF1/CIP1 expression in superficial bladder cancerN H Chow, T S Tzai, H L Cheng, et al.Cancer Gene Therapy|June 23, 2009
Enhancement of antitumor activity of gammaretrovirus carrying IL-12 gene through genetic modification of envelope targeting HER2 receptor: a promising strategy for bladder cancer therapyY-S Tsai, A-L Shiau, Y-F Chen, et al.Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|March 1, 1989
Transrectal sonography of the prostate and seminal vesicles on patients with hemospermiaT S Tzai, C L Chang, C R Yang, et al.Clinical Science (London, England : 1979)|June 1, 1995
Clinical significance of urinary ferritin excretion in patients with transitional cell carcinomaN H Chow, C J Chang, P E Cheng, et al.Clinical Science (London, England : 1979)|February 1, 1996
Implications of urinary basic fibroblast growth factor excretion in patients with urothelial carcinomaN H Chow, C J Chang, T M Yeh, et al.Urology|December 4, 1998
Potential value of urinary intercellular adhesion molecule-1 determination in patients with bladder cancerN H Chow, C J Cheng, Y C Chi, et al.Urological Research|January 1, 1994
An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseasesN H Chow, T S Tzai, P E Cheng, et al.Anticancer Research|May 1, 1994
Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancerS E Lee, N H Chow, Y C Chi, et al.Anticancer Research|November 1, 1995
Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinomaW J Yao, C J Chang, S H Chan, et al.The Journal of Urology|June 1, 1989
Impotence evaluated by the use of prostaglandin E1T I Hwang, C R Yang, S J Wang, et al.Pageof 5